News articles tagged 'Pharmaceuticals'

Controversy over gene patents

A controversial decision on the patentability of human genes has been issued in the United States of America, which could have a significant impact on the biotechnology and pharmaceutical industries. Read More

Pharma & Biotech: EPO Enlarged Board of Appeal Decision G2/08

The decision confirms the patentability of novel and inventive dosage regimes and also clarifies the style of claims allowed in Europe where a known medicament has been found to be useful for a new therapeutic treatment. Read More

Pharmaceutical battle in New Zealand

New Zealand is a country with a small GDP, as of 2009, only US$100 billion, one-eighteenth the size of California’s, and a small population of only 4. 3 million, just one- ninth the size of California’s. Read More

AstraZeneca wins against Pharmac

The Pharmaceutical Management Agency (Pharmac) is responsible for managing the pharmaceutical budget for New Zealand’s public health system. In particular, Pharmac decides which medicines will be subsidised. Read More

Australian Patent Term Extensions - Pharmaceutical Substance Combinations

Two recent cases before the Australian Patent Office highlight what can be a problem area when seeking to extend patent term under the Australian Patents Act 1990. Read More

Harmonisation and net technology importers

How developing countries deal with patent protections on life-saving medecines in a global world. There is increasing pressure, particularly from developed countries and multinational companies, for harmonisation of the patent system. Read More